Opportunities - Research Study to Help Canadians Reduce Their Risk of Heart Disease
Research Study to Help Canadians Reduce Their Risk of Heart Disease
The University of Alberta
Heart disease is one of the leading causes of death in Canada, accounting for nearly one in three deaths each year. The risk factors for heart disease are well known, but people in the community need more support managing them in order to reduce their risk of heart disease.
Pharmacists are well-respected health professionals who see patients with chronic diseases frequently, and as such they are well positioned to identify people who are at risk for heart disease and work with them to reduce their risk.
This study aims to determine the impact of a pharmacist-led care pathway to improve heart health on individuals’ risk for heart disease. This pharmacist-led care pathway will involve in-person appointments with a pharmacist to calculate a person’s risk for having a heart attack or stroke. The pharmacist will provide recommendations and information leaflets on how to reduce the person’s risk for heart disease. The person may continue to see the pharmacist during follow-up appointments.
The potential impact of this project is to empower people to understand how to reduce their risk of heart disease and reduce the burden of heart disease on the community.
Roles and responsibilities
We wish to invite two patient partners with lived experience of heart disease or stroke into this project to provide feedback from a patient’s perspective on the design of the study, including the study proposal and pharmacist-led care pathway for managing the risk of heart attack or stroke. Engagement would include joining study meetings and reviewing study documents to provide comments. The project is anticipated to take up to two years but the patient partners contribution may be for a shorter duration as available.
The project is anticipated to start February 2024 and continue until February 2026. Online meetings may be held up to every two weeks and are expected to last for 1 hour.
Patient partners will be offered compensation at a rate of $25/hour.
Patient partner contributions will be acknowledged in any research publications or presentations resulting from this study.
For more information or to apply